Development of defence medical countermeasures

Last updated: 18.7.2025
Grant

The "Development of Defence Medical Countermeasures" program, part of the European Defence Fund (EDF), aims to enhance the EU's strategic autonomy in addressing Chemical, Biological, Radiological, and Nuclear (CBRN) threats. It provides funding for the innovation and development of medical countermeasures crucial for both armed forces and civilian protection. This initiative fosters shared capabilities and strengthens the EU's industrial capacity in defence medical technologies.

Who is Funded

This section details the eligibility criteria for applicants, the geographical scope of projects, and the core objectives of the "Development of Defence Medical Countermeasures" program. It outlines who can apply, where the projects should have an impact, and what the program aims to achieve in strengthening EU defence capabilities against CBRN threats.

What is Funded

This section describes the types of projects and activities supported by the "Development of Defence Medical Countermeasures" program, outlining the thematic areas, eligible activities, and targeted development stages. It clarifies the scope of innovations and developments expected to enhance CBRN defence.

Type and Scope of Funding

This section outlines the financial aspects of the "Development of Defence Medical Countermeasures" program, including the type of financial support, the overall budget allocated, and the expected project duration. It provides clarity on the nature and scale of funding available.

Conditions and Requirements

This section details the essential conditions and requirements for participation in the "Development of Defence Medical Countermeasures" program, covering admissibility criteria, application guidelines, and consortium rules. Adherence to these provisions is crucial for successful application and project implementation.

Application Procedure

This section outlines the procedural steps for applying to the "Development of Defence Medical Countermeasures" program, from preparing the necessary documentation to understanding the evaluation and award processes.

This section identifies the foundational legal frameworks and official documents that underpin the "Development of Defence Medical Countermeasures" program, establishing its authority and operational guidelines.

Similar Programs

#Development of defence medical countermeasures#CBRN defence#medical countermeasures development#EU armed forces#biological threats#chemical threats#radiological threats#European Defence Fund#defence innovation#military health protection#MCM research#CBRN medical protection#EU strategic autonomy#preclinical trials#clinical trials#vaccines development#diagnostics development#broad-spectrum MCMs

Funding Overview

Funding Status

Funding Status:

Closed

Allocated Budget

Allocated Budget:

50,000,000 € (for 2021)

Deadline

Deadline:

08.12.2021

Open Until

Open Until:

31.12.2027

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union

Sectors

Sectors:

Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Other

Beneficiaries

Beneficiaries:

EU armed forces, civilian sector

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Feasibility Study, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Scaling, Commercialization

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

European Commission

0 x 0
XS